![Daniel Bohsen](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Profile
Daniel Bohsen is President, Treasurer & Director at Akero Therapeutics, Inc. since 2025.
Mr. Bohsen was Vice President & Head-Investor Relations at Novo Nordisk A from 2020 to 2024.
Daniel Bohsen active positions
| Companies | Position | Start |
|---|---|---|
| AKERO THERAPEUTICS, INC. | President | 2025-12-08 |
Former positions of Daniel Bohsen
| Companies | Position | End |
|---|---|---|
| NOVO NORDISK A/S | Investor Relations Contact | 2024-04-30 |
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
6
1st degree connections
2
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 2 |
|---|---|
Novo Nordisk A/S
 Novo Nordisk A/S Pharmaceuticals: MajorHealth Technology Manufactures and markets pharmaceutical products for diabetes care | Health Technology |
Akero Therapeutics, Inc.
 Akero Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops therapies for patients with metabolic diseases | Health Technology |
- Stock Market
- Insiders
- Daniel Bohsen
Choose MarketScreener 
